Articles by RJ Mackenzie

A statistical model using two measures of brain activity could anticipate if people given an injection would be in severe pain for the next month.

An enzyme reconstructed from a three-billion-year-old bacterium widens gene editing capabilities to even more regions of the genome.

Injectable micelles that release glucagon could provide a new way to treat hypoglycemic events in diabetes.

A new vaccination schedule pumps up the immune response to human immunodeficiency virus, overcoming a barrier that has frustrated vaccine designers.

The therapy met its primary endpoints in two Phase 3 studies and offers a new approach for the tens of millions of people living with the psychiatric condition.

The new complex is inexpensive to produce, and its unique architecture makes chemical reactions integral to drug discovery more stable and efficient.

Engineered peptides that mimic molecules of the innate immune system act synergistically with available drugs to treat Candida albicans in an animal model.

In a mix of innovation and accident, researchers developed a new antibiotic that has broad efficacy across Gram-positive bacteria.

Nonhuman primates treated with the mRNA vaccine recovered faster and had less severe disease than those given available mpox vaccines. 

Fiber found in bananas and garlic suppressed allergic reactions in mice.

An FDA advisory panel voted against recommending the psychedelic MDMA for PTSD, puncturing excitement around the drug’s potential.